|
CASC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.084200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.434040E-02 |
| Normal-vs-Stage2 |
9.377500E-02 |
| Normal-vs-Stage3 |
9.816000E-01 |
| Normal-vs-Stage4 |
7.816000E-01 |
| Stage1-vs-Stage2 |
4.845800E-01 |
| Stage1-vs-Stage3 |
1.034400E-01 |
| Stage1-vs-Stage4 |
3.010300E-02 |
| Stage2-vs-Stage3 |
1.050640E-01 |
| Stage2-vs-Stage4 |
8.661700E-02 |
| Stage3-vs-Stage4 |
8.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.691700E-02 |
| Normal-vs-AfricanAmerican |
2.935800E-01 |
| Normal-vs-Asian |
3.475800E-01 |
| Caucasian-vs-AfricanAmerican |
1.347600E-02 |
| Caucasian-vs-Asian |
4.909000E-01 |
| AfricanAmerican-vs-Asian |
7.728500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.518000E-01 |
| Normal-vs-Female |
3.782000E-02 |
| Male-vs-Female |
2.970000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.610600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.251800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.453200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.964200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.679600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.911840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.131600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.247200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.107000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.870800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.145400E-01 |
| Normal-vs-Grade 2 |
9.918800E-03 |
| Normal-vs-Grade 3 |
3.246800E-01 |
| Normal-vs-Grade 4 |
4.962100E-02 |
| Grade 1-vs-Grade 2 |
8.487600E-01 |
| Grade 1-vs-Grade 3 |
2.782400E-01 |
| Grade 1-vs-Grade 4 |
2.641800E-02 |
| Grade 2-vs-Grade 3 |
6.505600E-02 |
| Grade 2-vs-Grade 4 |
1.177760E-04 |
| Grade 3-vs-Grade 4 |
4.978500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.610000E-04 |
| Normal-vs-ccB subtype |
3.608000E-01 |
| ccA subtype-vs-ccB subtype |
2.230200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.794400E-02 |
| Normal-vs-N1 |
7.197800E-01 |
| N0-vs-N1 |
7.355200E-01 |
|
|
